Daily Undulating Periodization Methods With Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Parkinson DiseaseWeight-Lifting Exercise Program
Interventions
OTHER

Periodized training with motor practice

Exercises at 75-80% of the subject's maximum for strength exercise using contractions with 2 second concentric and 3 second eccentric for the strength day. 30-80% of subjects' maximal strength for the power day with high-speed concentric and 2 second eccentric contractions, and exercises that simulate activities of daily living for the motor practice day. All resistance-training will be performed on Keiser air-driven machines. Subjects will perform 10 exercises targeting all major muscle groups. The training will last for 12 consecutive weeks, for a total of 36 visits. Each visit will be approximately 60 minutes long and will consist of 5 minutes warm-up, 50 minutes of training and five minutes of cool-down.

OTHER

Simple Periodized Training

Exercises at 75-80% of the subject's maximum for strength using contractions with 2 second concentric and 3 second eccentric for the strength day. 30-80% of subjects' maximal strength for the power day, with high speed concentric and 2 second eccentric contractions, and for hypertrophy day at 60-75% of subjects' maximum strength. All resistance-training will be performed on Keiser air-driven machines. Subjects will perform 10 exercises targeting all major muscle groups. The training will last for 12 consecutive weeks, for a total of 36 visits. Each visit will be approximately 60 minutes long and will consist of 5 minutes exercise using contractions warm-up, 50 minutes of training and five minutes of cool-down.

Trial Locations (2)

33146-2416

Max Orovitz Laboratories, Coral Gables

Max Orovitz Laboratory, Coral Gables

All Listed Sponsors
lead

University of Miami

OTHER

NCT03867877 - Daily Undulating Periodization Methods With Parkinson's Disease | Biotech Hunter | Biotech Hunter